Pregnant, breastfeeding, or pediatric patients Human data on multi-enzyme OTC supplements in pregnancy, breastfeeding, and young children are limited
The therapeutic effect and in vivo assessment of Palmitoyl-GDPH on the wound healing process
A 2016 systematic review of clinical evidence on newer vs older diabetes medications supports metformin as 1st-line therapy for type 2 diabetes given its relative safety & beneficial effect to lower HbA1c, absence of weight gain, and reduced cardiovascular mortality (Maruthur et al, 2016)
These discussions are limited to in vitro and in vivo research models and do not imply approved applications, outcomes, or therapeutic use
Unlike PDE5 inhibitors that act peripherally, PT-141 works centrally